GlassScriptPhysician profile
Melissa Chinn
NPI 1336125343
$1,109.12
in general payments reported to CMS, 2019-2025
13 companies · $89.79 in 2025
The $89.79 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.41 · 2020: $78.49 · 2021: $268 · 2022: $330 · 2023: $315 · 2025: $89.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $260.64 | 2021-2022 | |
| Abbvie INC. | $164.41 | 2020-2025 | |
| Novo Nordisk INC | $130.98 | 2023 | Ozempic, Rybelsus |
| Medtronic, INC. | $130.55 | 2023 | Venaseal |
| Gen-Probe Sales & Service, INC. | $93.87 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $75.61 | 2021 | |
| Minerva Surgical, INC | $69.27 | 2025 | |
| Hologic Sales and Service, LLC | $67.54 | 2019-2022 | |
| Mycovia Pharmaceuticals, INC. | $53.32 | 2023 | Vivjoa |
| Ascend Therapeutics US, LLC | $25.00 | 2022 | |
| Agile Therapeutics, INC. | $14.30 | 2021 | |
| Therapeuticsmd, INC. | $11.88 | 2021 | |
| Avion Pharmaceuticals | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Chinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.